Figure (Mid0e 0002 01)
Midazolam Injection, Solution
Product Images NDC 63323-411
19 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 63323-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula (Mid0e 0002 02)
Chemical structure of Midazolam Hydrochloride, showing the molecular arrangement including fused rings with chlorine and fluorine substituents and the hydrochloride component.*
Figure (Mid0e 0002 03)
Chemical structure diagram showing Midazolam and its open-ring form. The image displays the molecular representations of Midazolam and its reversible transformation to the open-ring form, illustrating specific structural components including chlorine and fluorine atoms.*
Figure (Mid0e 0002 04)
A graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of open-ring form on the y-axis and pH values ranging from 2.5 to 5.5 on the x-axis. The plot indicates a sharp decrease in the percentage of open-ring form as pH increases from about 50% at pH 2.5 to near 0% at pH 5.5.*
Figure (Image 01)
Midaz-label-01.jpg (Midaz Label 01)
Label of Midazolam Injection, USP, 2 mg per 2 mL (1 mg per mL) solution for injection. The label indicates intramuscular or intravenous use and that the 2 mL vial contains benzyl alcohol. Labeler is Fresenius Kabi USA, LLC, with NDC 63323-411-22.*
Midaz-label-02.jpg (Midaz Label 02)
Midazolam Injection, USP 1 mg/mL (2 mg per 2 mL) solution for intramuscular or intravenous use. The label mentions the active ingredient Midazolam hydrochloride at 1 mg per mL, contains benzyl alcohol preservative, and comes in 25 vials of 2 mL each. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and container details included.*
Vial (Mid0e 0002 06)
Midazolam Injection, USP 2 mg per 2 mL (1 mg per mL) vial labeled for intramuscular or intravenous use. The label states it contains benzyl alcohol and is a 2 mL vial. The labeler is Fresenius Kabi USA, LLC, with a visible NDC 63323-411-15 and barcode.*
Tray (Mid0e 0002 07)
Label for Midazolam Injection, USP 1 mg/mL (2 mg per 2 mL vial) by Fresenius Kabi USA, LLC. It is for intramuscular or intravenous use, supplied as 25 vials of 2 mL each. The label includes storage instructions, ingredient details, and a barcode.*
Vial (Mid0e 0002 08)
Midazolam Injection, USP 1 mg/mL in a 5 mL vial by Fresenius Kabi USA, LLC. The label indicates a strength of 5 mg per 5 mL, for intramuscular or intravenous use only. Contains benzyl alcohol as a preservative. Storage instructions for 20° to 25°C (68° to 77°F) are provided alongside barcode and lot/expiration information.*
Tray (Mid0e 0002 09)
Midazolam Injection, USP 5 mg per 5 mL (1 mg per mL) solution for injection vials by Fresenius Kabi USA, LLC. Label states it is for intramuscular or intravenous use only, contains benzyl alcohol, and the package contains 25 vials of 5 mL each. Storage instructions and formulation details are also shown on the label.*
Vial (Mid0e 0002 10)
Midazolam Injection, USP, 10 mg per 10 mL (1 mg/mL) solution for injection vial labeling from Fresenius Kabi USA, LLC. The label indicates use for intramuscular or intravenous injection, contains benzyl alcohol, and storage instructions at 20° to 25°C (68° to 77°F). The NDC is 63323-411-13.*
Tray (Mid0e 0002 11)
Midazolam Injection, USP 10 mg per 10 mL (1 mg per mL) vial label for intramuscular or intravenous use. Contains benzyl alcohol. Pack of 10 x 10 mL vials. Manufactured by Fresenius Kabi USA, LLC. Includes storage instructions and ingredients information, and barcode.*
Vial (Mid0e 0002 12)
Label for Midazolam Injection USP 5 mg per 1 mL in a 1 mL vial by Fresenius Kabi USA. It is intended for intramuscular or intravenous use only and contains benzyl alcohol as a preservative. The label includes the NDC 63323-412-18 and features a barcode and lot/expiration date area.*
Tray (Mid0e 0002 13)
Midazolam Injection, USP 5 mg per 1 mL (5 mg/mL) solution for intramuscular or intravenous use. The label indicates a package of 25 vials, each 1 mL, containing benzyl alcohol as a preservative. Manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL. Important storage instructions and formulation details are also included on the label.*
Vial (Mid0e 0002 14)
Label for Midazolam Injection, USP 10 mg per 2 mL (5 mg per mL) solution by Fresenius Kabi. The label indicates intramuscular or intravenous use, contains benzyl alcohol, and the vial size is 2 mL. The NDC on this label is 63323-412-03.*
Tray (Mid0e 0002 15)
Label for Midazolam Injection, USP, 10 mg per 2 mL (5 mg per mL) solution, for intramuscular or intravenous use. The package contains 10 vials of 2 mL each. The label indicates the presence of benzyl alcohol and includes storage instructions and manufacturer Fresenius Kabi USA, LLC, Lake Zurich, IL.*
Vial (Mid0e 0002 16)
Label for Midazolam Injection, USP containing 50 mg per 10 mL (5 mg per mL) solution for intramuscular or intravenous use. The label notes benzyl alcohol as a preservative and includes storage instructions to keep at 20° to 25°C. The vial size is 10 mL. The product is labeled by Fresenius Kabi USA, LLC, with an NDC of 63323-412.*
Tray (Mid0e 0002 17)
Midazolam Injection, USP 5 mg/mL (50 mg per 10 mL) solution for injection by intramuscular or intravenous use. Pack contains 10 vials of 10 mL each. Label indicates the product contains benzyl alcohol and details storage instructions at 20° to 25°C. Manufactured by Fresenius Kabi USA, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
